Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
US5859228A · kind A · utility
35Cited by
11References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 1996 |
| Grant date | Jan 12, 1999 |
| Priority date | — |
| Expiry date | Oct 25, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/3515
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention discloses a method for preparing a complex comprised of a VEGF Nucleic Acid Ligand and a Lipophilic Compound by identifying a VEGF Nucleic Acid Ligand by SELEX methodology and associating the VEGF Nucleic Acid Ligand with a Lipophilic Compound. The invention further discloses Complexes comprising one or more VEGF Nucleic Acid Ligands in association with a Lipophilic Compound. The invention further includes a Lipid construct comprising a VEGF Nucleic Acid Ligand or Complex and methods for making the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.